Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

Presentation discusses the evolution of the patient assistance landscape, while presenting ways to collaborate. 

PAP 2024: Teaming Up on Patient Assistance

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Tiara Green, Interim CEO, Accessia Health offers insight on challenges faced by patient assistance organizations and how to face them. 

PAP 2024: Tiara Green Discusses Challenges of Patient Assistance Organizations

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC offers his thoughts on the Inflation Reduction Act and discusses current advocacy efforts. 

PAP 2024: John Hoffman Discusses the Inflation Reduction Act and Current Advocacy Efforts

The latest news for pharma industry insiders.

Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

Hubs East 2024: Leveraging Digital Hubs

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, PAN Foundation offers her thoughts on the session and feedback from the audience at PAP 2024 in Philadelphia. 

PAP 2024: Amy Niles Discusses Moderating the State of Patient Access and Affordability Breakout Session

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes. 

PAP 2024: Embracing the Power of Artificial Intelligence

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups. 

PAP 2024: Monique French Discusses Effective Ways to Engage Patients, Caregivers, and Advocacy Groups

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the important and often missing element in strategic planning for clinical-stage companies—and ways to close that focus gap.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right